Health
Study links metformin to slowed cognitive decline – Australian Hospital + Healthcare Bulletin
A study of older Australians with type 2 diabetes revealed that taking metformin resulted in slower cognitive decline with lower dementia rates than those who d…
Used by millions of people across the globe to optimise blood glucose levels, metformin is regarded as the first-line treatment for most cases of type 2 diabetes.
A six-year study of older Australians with type 2 diabetes has revealed that those taking metformin experienced slower cognitive decline with lower dementia rates than those who did not use the medication.
Led by researchers at the Garvan Institute of Medical Research and the Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney, the …
-
Noosa News19 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General18 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
General21 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
General10 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging